March 19, 2015

The House Energy & Commerce Health Subcommittee on Health hearing entitled, “Examining the 340B Drug Pricing Program”, originally scheduled for Thursday, March 5th has been RESCHEDULED for March 24, 2015 at 10:00 a.m. EST.

The purpose of the hearing will be to review the functionality of the program to understand how it impacts patients, providers, manufacturers, and other stakeholders. The event will be available via webcast here.


This webcast offers the health care provider community and other 340B stakeholders a unique opportunity to hear the specific compliance issues and concerns that Congress has with the program, as well as the opinions and responses of those government agencies that have been administering and examining the 340B Program in recent years. Witnesses at the hearing include Diana Espinosa, Deputy Administrator of Health Resources and Services Administration, accompanied by CDR Krista M. Pedley, Director of the Office of Pharmacy Affairs; Debbie Draper, Director, Health Care, of the Government Accountability Office; and Anne Maxwell, Assistant Inspector General for Evaluation and Inspections, Office of Inspector General.

To read the full alert, click here.